$RGBP -Will Exceed ENCZ's run in Feb: Target: $1.50-$3.00 WHY? ENZC had #1 (1) Patent only #2 No FDA approval #3 No licensing arrangements #4 No partnerships #5 No catalysts #6 No PR releases #7 No prospect of revenue (due to #2 & #3) #8 No suggestion of Buy Out by CEO RGBP has #1 (24) Patents worth BILLIONS patents.google.com/?invento... #2 Licensing of (1) Patent w/(2) INDs (New Drug Applications) for treating pancreatic & colon cancer by mRNA Vaccine "The Future of Medicine" finance.yahoo.com/news/its-... #3 Patent Approval for Clinical Trials newsinvasion24.com/regen-bi... #4 Partnership:Oncology Pharma Paid $1M for Patent Licensing; NOW Positioned to Post Quarterly Revenues for 15 YEARS! (This is indicative of a NASDAQ Stock unlike any OTC) #5 Pink Current-World Wide Buying IN PROGRESS #6 CEO suggests Buy Out:8K Filed 4/27/21 to prevent Hostile Take Over that says "parties seeking to ACQUIRE must negotiate directly." #7 Big Pharmas to Acquire RGBP/Possible Bidding WAR reddit.com/r/RGBP/comments/...
21
15
15 Likes